Le Lézard
Classified in: Health
Subjects: NPT, VET

Disabled Veterans National Foundation awards $357,000 in Capacity Building Grants to 25 non-profit veteran support organizations


The Disabled Veterans National Foundation is pleased to announce that this spring, the organization will award $357,000 in grants to twenty-five non-profit veteran support organizations.

LANHAM, Md., June 7, 2023 /PRNewswire-PRWeb/ -- The Disabled Veterans National Foundation is pleased to announce that this spring, the organization will award $357,000 in grants to twenty-five non-profit veteran support organizations.

With this funding, these organizations can offer a wide variety of services and support to disabled and at-risk veterans. The charities vary in size, mission, and focus, and grants were awarded based on the size of the grant request, and the direct impact they have within Veteran communities.

"Our Veterans deserve every bit of support and assistance they can receive during these difficult times," said Ret. Sgt. Maj Joseph VanFonda, Chief Executive Officer of the DVNF. "Our Grant program is a direct way to demonstrate our financial support for these non-profit organizations that provide much-needed assistance to our homeless, disabled, and at-risk veterans and their families."

Spring 2023 Grant recipients are listed below:

Warriors on the Way: VLMC Charities: Veterans Alternative, Inc. DBA Warrior Wellness Program: Veterans Resilience Project Inc: Adaptive Sports Program of Ohio: Assistant Dogs of the West: Brighter Way Institute: Brow and Housing Solutions: Central Oregon Veteran Ranch: Central Union Mission: Clear Path for Veterans Inc: Community Rowing Inc: Continue Mission: Dreams on Horseback: Fathers and Mothers who Care: Habits for Humanity of Greater Cincinnati: Leukemia & Lymphoma Society, Inc: Mercy Housing Lakefront: Mercy Medical Angels: Oklahoma Dental Foundation for Research and Education: Project Sanctuary: Soldiers Angels: Stable Strides: The Veteran K-9 Corps (American Vet Dogs): Trustees of Tufts College:

Please follow us:

? Facebook: https://www.facebook.com/dvnf

? Twitter: https://twitter.com/TheDVNF

? Instagram: https://www.instagram.com/thedvnf

ABOUT DISABLED VETERANS' NATIONAL FOUNDATION

The DVNF, a 501(c)(3) national non-profit organization is dedicated to providing critically needed support to disabled and at-risk veterans who leave the military wounded?physically or psychologically?after defending our safety and our freedom in combat. For more information visit: https://www.dvnf.org/

Pull Quote

"Our Veterans deserve every bit of support and assistance they can receive during these difficult times," said Ret. Sgt. Maj Joseph VanFonda

Media Contact

PATRICK HERON, Disabled Veterans National Foundation, 1 (202) 277-6484, pheron@dvnf.org, https://www.dvnf.org/

 

SOURCE Disabled Veterans National Foundation


These press releases may also interest you

3 oct 2023
Global Peptone Market Analysis Report 2023-2028: Biopharmaceutical Boom Drives Demand for Peptone in Fermentation Processes
The "Global Peptone Market Report and Forecast 2023-2028" report has been added to  ResearchAndMarkets.com's offering. Global peptone market is forecasted to reach a value of $210 million by 2028 from $166.12 million in 2023, growing at a CAGR of...

3 oct 2023
EntroGen Receives FDA Approval for CRCdx® RAS Mutation Detection Kit as Companion Diagnostic for Vectibix®
The U.S. Food and Drug Administration (FDA) has granted approval for EntroGen's CRCdx® RAS Mutation Detection Kit as a companion diagnostic for Vectibix® (panitumumab), a targeted therapy used in the treatment of colorectal cancer. This landmark...

3 oct 2023
Radiopharmaceuticals Market size to grow by USD 4.61 billion from 2022 to 2027, North America to account for 42% of market growth - Technavio
The radiopharmaceuticals market size is expected to grow by USD 4.61 billion from 2022 to 2027. In addition, the momentum of the market will be progressing at a CAGR of 10.22% during the forecast period, according to Technavio Research. The market...

3 oct 2023
FDA Grants Transcenta Clearance to Proceed with Global Phase III Trial of Osemitamab (TST001) as First-Line Treatment for Gastric/Gastroesophageal Cancer Patients
Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces that FDA has...

3 oct 2023
Global Liquid Dosage Excipients Market Research Report 2023: Burgeoning Opportunities in mRNA-based Therapeutics & Increasing Need for an Independent Approval Pathway for Novel Excipient Development
The "Global Liquid Dosage Excipients Growth Opportunities" report has been added to  ResearchAndMarkets.com's offering. The global study on the liquid dosage excipients assesses growth opportunities in the oral liquid and parenteral excipients...

3 oct 2023
Colorado Access Welcomes new Chief Communications and Member Experience Officer
Colorado Access announces the appointment of Jaime Moreno as the organization's new chief communications and member experience officer. This newly created position at Colorado Access is a testament to the organization's commitment to providing the...

More news about Health...


News published on and distributed by: